Your browser doesn't support javascript.
loading
Unpacking the relationship between shared decision-making and decisional quality, decision to screen, and screening completion in lung cancer screening.
Carter-Bawa, Lisa; Slaven, James E; Monahan, Patrick O; Brandzel, Susan; Gao, Hongyuan; Wernli, Karen J; Lafata, Jennifer Elston; Rawl, Susan M.
Afiliação
  • Carter-Bawa L; Center for Discovery & Innovation at Hackensack Meridian Health, Nutley, NJ, USA; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA. Electronic address: lisa.carterbawa@hmh-cdi.org.
  • Slaven JE; Indiana University School of Medicine, Department of Biostatistics and Health Data Science, Indianapolis, IN, USA.
  • Monahan PO; Indiana University School of Medicine, Department of Biostatistics and Health Data Science, Indianapolis, IN, USA.
  • Brandzel S; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
  • Gao H; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
  • Wernli KJ; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
  • Lafata JE; UNC Eshelman School of Pharmacy and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC, USA.
  • Rawl SM; Indiana University School of Nursing, Indianapolis, IN, USA; Indiana University Melvin & Bren Simon Comprehensive Cancer Center, Indianapolis, IN, USA.
Patient Educ Couns ; 122: 108143, 2024 May.
Article em En | MEDLINE | ID: mdl-38237528
ABSTRACT

OBJECTIVES:

Lung cancer screening is a complex and individualized decision. To understand how best to support patients in this decision, we must understand how shared decision-making is associated with both decisional and behavioral outcomes.

METHODS:

Observational cohort study combining patient survey data with electronic health record data of lung screening-eligible patients who recently engaged in a shared decision-making discussion about screening with a primary care clinician.

RESULTS:

Using multivariable analysis (n = 529), factors associated with higher lung cancer screening decisional quality include higher knowledge (OR = 1.33, p < .0001), lower perceived benefits (OR = 0.90, p = .0004), higher perceived barriers (OR = 1.07, p < .0001), higher self-efficacy (OR = 1.13, p < .0001), and higher levels of perceiving the discussion was shared (OR = 1.04, p < .0001). Factors associated with the patient's decision to screen include older age (OR = 1.12, p = .0050) and higher self-efficacy (OR = 1.11, p = .0407). Factors associated with screening completion included older age (OR = 1.05, p = .0050), higher knowledge (OR = 1.24, p = .0045), and higher self-efficacy (OR = 1.12, p = .0003).

CONCLUSIONS:

Shared decision-making in lung cancer screening is a dyadic process between patient and clinician. As we continue to strive for high-quality patient-centered care, patient decision quality may be enhanced by targeting key factors such as high-quality knowledge, self-efficacy, and fostering a shared discussion to support patient engagement in lung cancer screening decisions.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tomada de Decisões / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Patient Educ Couns Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tomada de Decisões / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: Patient Educ Couns Ano de publicação: 2024 Tipo de documento: Article